Powered by

The world is watching the FDA's AstraZeneca decision

Apr 08, 2021 - Axios.com

AstraZeneca's coronavirus vaccine took yet another public relations hit yesterday, when the European Medicines Agency announced that the shot has a "possible" link to rare blood clots, and they should be listed as a "very rare" side effect of the vaccine.

What we're watching: Even before the link was announced, the U.S. didn't need the AstraZeneca vaccine, based on its existing supply of other shots. But what the Food and Drug Administration decides to do about the vaccine — if the com...